Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa

Walter Jaoko, Etienne Karita, Kayitesi Kayitenkore et al. · 2010

Read Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa by Walter Jaoko, Etienne Karita, Kayitesi Kayitenkore et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012873.txt.

Description

Jaoko, Karita, Kayitenkore and co-authors ran an early safety trial in Africa of a two-step HIV vaccine plan. Their 2010 study was a double-blind trial with placebo control, the strictest kind of early test. Volunteers received a recombinant adenovirus vaccine carrying HIV Gag and Pol genes, alone or after a DNA vaccine prime.

The team measured safety and how strongly immune systems answered. Early trials like this one decide whether a vaccine idea earns larger tests. Running them in Africa also ensures the data fit the populations most affected by HIV.

Catalog record

CREATORWalter Jaoko, Etienne Karita, Kayitesi Kayitenkore et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE68 KB
LICENSECreative Commons CC0 License
RIGHTSCC0
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012873

Browse the full library · About the Tower of Babel